Inventaire - your friends and communities are your best library - Inventaire

Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus

published in: Journal of the American Society of Nephrology

date of publication: 2011-03-17

main subject: type 2 diabetes, circulatory system

Cites articles 43

Date

Title

Authors

2010-01-22

The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial

Valentina Milani, Aldo P. Maggioni, Luigi Tavazzi
2010-01-01

Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort
2010-01-06

Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy

Takashi Akiba
2009-12-01

Copeptin: a novel, independent prognostic marker in patients with ischemic stroke

Roland Bingisser, Ludwig Kappos, Mirjam Christ-Crain
2009-12-01

Glycemic control and cardiovascular events in diabetic hemodialysis patients

Winfried März
2009-06-29

Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes

Guido Strunk
2009-05-20

Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin
2009-01-21

Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis

Johann Bauersachs
2009-02-01

Gender and renal function influence plasma levels of copeptin in healthy individuals

Leong L Ng
2009-11-02

Prognostic value of emerging neurohormones in chronic heart failure during optimization of heart failure-specific therapy

Guido Strunk
2009-08-01

Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients
2009-04-03

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.

Stephan von Haehling, Stefan D. Anker, Dirk J van Veldhuisen, Kenneth Dickstein, Hans L Hillege, Adriaan A Voors, Joachim Struck, Iain Squire
2009-03-01

Plasma levels of copeptin in patients with coronary heart disease
2008-07-01

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease

Guido Strunk
2008-07-09

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.

Winfried März
2008-05-01

Non-peptide arginine-vasopressin antagonists: the vaptans

Gilbert Vassart
2008-03-27

The challenge of sudden death in dialysis patients
2008-08-30

C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction

Leong L Ng
2008-09-21

Use of copeptin in the detection of myocardial ischemia
2008-09-24

Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis

Winfried März
2007-04-09

C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study

Leong L Ng
2007-03-19

Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.

Johann Bauersachs
2007-02-01

Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
2007-09-26

Development of renin expression in the mouse kidney

Alexander W Sauter
2006-05-27

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

Alan D. Lopez, Christopher J.L. Murray, Majid Ezzati, Colin D Mathers
2006-11-01

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.
2006-02-27

Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats
2005-11-03

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin
2005-07-01

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Winfried März
2005-01-28

RALES, EPHESUS and redox
2003-03-31

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

Faiez Zannad, Bertram Pitt, James D Neaton, Willem J. Remme, Barbara Roniker, Jay Kleiman
1999-09-02

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Article - wd:Q34726918

Welcome to Inventaire

the library of your friends and communities

you are offline